Dr. Lusch is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1617 Meadowlark Rd
Reading, PA 19610Phone+1 610-334-3433- Is this information wrong?
Education & Training
- Drexel University College of Medicine/Hahnemann University HospitalFellowship, Hematology and Medical Oncology, 1967 - 1968
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1965 - 1967
- Tower HealthResidency, Internal Medicine, 1962 - 1965
- Tower HealthInternship, Transitional Year, 1961 - 1962
- Lewis Katz School of Medicine at Temple UniversityClass of 1961
- Lafayette CollegeA.B., Magna Cum Laude, 1953 - 1957
Certifications & Licensure
- PA State Medical License 1962 - 2024
- HI State Medical License 2003 - 2020
- SC State Medical License 1988 - 2005
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Recognition Best Doctors, 1996-2014
- Senate Award for service to patients of central Pennsylvania Pennsylvania Senate, 2008
- First "Healthcare Champion" Berks County VNA, 2008
- Join now to see all
Publications & Presentations
PubMed
- 15 citationsAssessing Compliance with National Comprehensive Cancer Network Guidelines for Elderly Patients with Stage III Colon Cancer: The Fox Chase Cancer Center Partners' Init...Margaret A. O'Grady, Elyse Slater, Elin R. Sigurdson, Neal J. Meropol, Alan Weinstein, Charles J. Lusch, Elaine Sein, Patricia A. Keeley, Bonnie J. Miller, Paul F. Eng...> ;Clinical Colorectal Cancer. 2011 Jun 1
- 26 citationsPhase II trial of topotecan in advanced or metastatic adenocarcinoma of the pancreas.Richard Scher, R Kosierowski, Charles J. Lusch, Roland Alexander, Stephen Fox, Istvan Redei, Fran Green, Barbara Raskay, Kweku Amfoh, Paul F. Engstrom, Peter J. O'Dwyer> ;Investigational New Drugs. 1995 Dec 1
- 45 citationsThe pennsylvania hemophilia program 1973–1978M. Elaine Eyster, Jessica H. Lewis, Sandor S. Shapiro, Frances M. Gill, Mehdi Kajani, David Prager, Isaac Djerassi, Samuel A. Rice, Charles J. Lusch, Anne Keller> ;American Journal of Hematology. 1980 Nov 1
- Join now to see all
Journal Articles
- Phase II Pilot Study of Daly Oral Etoposide and Hexamethylmelamine (Altretamine) In Small Cell Carcinoma of the LungLanger C.; Sprandio J.; Lusch, C.; Rousch R.; Kosierowski R.; Ozols R.; Fox S.; Reilly R.; Sarker C.R.; Galligher C., American Society of Clinical Oncology, 1/1/1999
- A Phase II Confirmatory Study of Antitumor Efficacy and Safety of Exemestane (EXE) As Third-Line Hormonal Treatment of Postmenopausal Patients (PTS) With Metastatic Br...Jones S.; Chang A.; Lusch C.; Belt R.; Arkhipov A.; Royer M.; Polli A.; di Salle E.; Miller L., Proceedings of the San Antonio Breast Cancer Conference, 1/1/1998
- Radionuclide Resting Left Ventricular Ejection Fraction (LVEF/MUGA Measurements in Breast Cancer Patients Receiving Adriamycin Based Chemotherapy for Advanced DiseaseD.V. Spicer; Lusch, C.J., Proceedings from the 1992 American Society of Clinical Oncology, 1/1/1992
- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: